L
Lori J. Silveira
Researcher at University of Colorado Denver
Publications - 81
Citations - 2481
Lori J. Silveira is an academic researcher from University of Colorado Denver. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 27, co-authored 62 publications receiving 1969 citations. Previous affiliations of Lori J. Silveira include Colorado School of Public Health & National Jewish Health.
Papers
More filters
Journal ArticleDOI
Association Between the MUC5B Promoter Polymorphism and Survival in Patients With Idiopathic Pulmonary Fibrosis
Anna L. Peljto,Yingze Zhang,Tasha E. Fingerlin,Shwu-Fan Ma,Joe G.N. Garcia,Thomas J. Richards,Lori J. Silveira,Kathleen O. Lindell,Mark P. Steele,James E. Loyd,Kevin F. Gibson,Max A. Seibold,Kevin K. Brown,Janet Talbert,Cheryl Markin,Karl Kossen,Scott D. Seiwert,Elissa Murphy,Imre Noth,Marvin I. Schwarz,Naftali Kaminski,David A. Schwartz +21 more
TL;DR: Whether the MUC5B promoter polymorphism (rs35705950), previously reported to be associated with the development of pulmonary fibrosis, is associated with survival in IPF is investigated to determine.
Journal ArticleDOI
Risk Factors for Severe COVID-19 in Children.
Kelly Graff,Christiana Smith,Lori J. Silveira,Sarah Jung,Shane Curran-Hays,Jane Jarjour,Lauren Carpenter,Kasey Pickard,Michael Mattiucci,JoEllen Fresia,Elizabeth J. McFarland,Samuel R. Dominguez,Samuel R. Dominguez,Lisa Abuogi +13 more
TL;DR: Extremes of age, comorbid conditions, and elevated CRP are predictors of severe disease in children.
Journal ArticleDOI
Response to sublingual immunotherapy with grass pollen extract: monotherapy versus combination in a multiallergen extract.
TL;DR: Improvement in multiple relevant outcomes strongly suggests that SLIT with timothy extract alone was effective; however, the results for symptom and medication scores were not significant.
Journal ArticleDOI
Influence of MHC CLASS II in Susceptibility to Beryllium Sensitization and Chronic Beryllium Disease
Lisa A. Maier,Dierdre S. McGrath,Hiroe Sato,P. A. Lympany,Ken Welsh,Roland M. du Bois,Lori J. Silveira,Andrew P. Fontenot,Richard T. Sawyer,Eric Wilcox,Lee S. Newman +10 more
TL;DR: It is concluded that DPB1 Glu69 is a marker of sensitization and not specific for disease, and glu69 homozygosity acts as a functional marker associated with markers of CBD severity.
Journal ArticleDOI
Risk analysis of early childhood eczema.
Hans Bisgaard,Liselotte Brydensholt Halkjaer,Rikke Hinge,Charlotte Giwercman,Colin N. A. Palmer,Lori J. Silveira,Matthew Strand +6 more
TL;DR: Dog exposure reduced the risk of eczema, whereas short length at birth, filaggrin mutation, and parental atopy increased the risk in children born of mothers with asthma by age 3 years.